(Q43825625)

27 November 2017

title

NMDA antagonist effects on striatal dopamine release: positron emission tomography studies in humans (English)

1 reference

positron emission tomography

27 November 2017

0 references

1 reference

1 reference

Lawrence S Kegeles

1

1 reference

27 November 2017

Diana Martinez

2

1 reference

27 November 2017

Lisa D Kochan

3

1 reference

27 November 2017

Dah-Ren Hwang

4

1 reference

27 November 2017

Yiyun Huang

5

1 reference

27 November 2017

Osama Mawlawi

6

1 reference

27 November 2017

R F Suckow

7

1 reference

27 November 2017

Ronald L Van Heertum

8

1 reference

27 November 2017

Marc Laruelle

9

1 reference

27 November 2017

publication date

1 January 2002

1 reference

27 November 2017

1 reference

27 November 2017

volume

43

1 reference

27 November 2017

issue

1

1 reference

27 November 2017

page(s)

19-29

1 reference

Alterations of benzodiazepine receptors in type II alcoholic subjects measured with SPECT and [123I]iomazenil

27 November 2017

cites work

1 reference

Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method

21 January 2018

1 reference

Effects of NMDA antagonism on striatal dopamine release in healthy subjects: application of a novel PET approach

21 January 2018

1 reference

Neurotransmitter interactions in schizophrenia--therapeutic implications

21 January 2018

1 reference

Quantification of amphetamine-induced changes in [11C]raclopride binding with continuous infusion

21 January 2018

1 reference

The binding of ketamine to plasma proteins: emphasis on human plasma.

21 January 2018

1 reference

Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats

21 January 2018

1 reference

Amphetamine-induced dopamine release in human ventral striatum correlates with euphoria.

21 January 2018

1 reference

Amphetamine-stimulated dopamine release competes in vivo for [123I]IBZM binding to the D2 receptor in nonhuman primates

21 January 2018

1 reference

Ketamine has equal affinity for NMDA receptors and the high-affinity state of the dopamine D2 receptor

21 January 2018

1 reference

Stability of [123I]IBZM SPECT measurement of amphetamine-induced striatal dopamine release in humans

21 January 2018

1 reference

Modulation of amphetamine-induced striatal dopamine release by ketamine in humans: implications for schizophrenia.

21 January 2018

1 reference

Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses

21 January 2018

1 reference

Comparison of methods for analysis of clinical [11C]raclopride studies.

21 January 2018

1 reference

Imaging synaptic neurotransmission with in vivo binding competition techniques: a critical review

21 January 2018

1 reference

Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects

21 January 2018

1 reference

Microdialysis and SPECT measurements of amphetamine-induced dopamine release in nonhuman primates

21 January 2018

1 reference

Imaging human mesolimbic dopamine transmission with positron emission tomography: I. Accuracy and precision of D(2) receptor parameter measurements in ventral striatum

21 January 2018

1 reference

Dopamine D(2) receptor availability and amphetamine-induced dopamine release in unipolar depression

21 January 2018

1 reference

Derivation of [(11)C]WAY-100635 binding parameters with reference tissue models: effect of violations of model assumptions.

21 January 2018

1 reference

Glutamate modulation of dopamine measured in vivo with positron emission tomography (PET) and 11C-raclopride in normal human subjects.

21 January 2018

1 reference

Decreased striatal dopaminergic responsiveness in detoxified cocaine-dependent subjects

21 January 2018

1 reference

Effects of (S)-ketamine on striatal dopamine: a [11C]raclopride PET study of a model psychosis in humans.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/SYN.10010

1 reference

27 November 2017

1 reference